# |
|
Family |
MCID |
Name |
MIFTS |
Score |
1 |
|
|
AGN016 |
Aging |
56 |
0.200 |
|
2 |
|
|
HYP066 |
Hyperglycemia |
61 |
0.188 |
|
3 |
|
P
|
NRP001 |
Neuropathy |
56 |
0.163 |
|
4 |
|
P
|
PRP019 |
Peripheral Nervous System Disease |
58 |
0.150 |
|
5 |
|
|
FTT001 |
Fatty Liver Disease |
61 |
0.137 |
|
6 |
|
P
|
CRD246 |
Cardiovascular System Disease |
57 |
0.130 |
|
7 |
|
|
NNL005 |
Non-Alcoholic Fatty Liver Disease |
61 |
0.130 |
|
8 |
|
|
GLC003 |
Glucose Intolerance |
54 |
0.130 |
|
9 |
|
P
|
KDN018 |
Kidney Disease |
72 |
0.128 |
|
10 |
|
c
|
CHR684 |
Chronic Kidney Disease |
70 |
0.124 |
|
11 |
|
P
|
PRT133 |
Proteasome-Associated Autoinflammatory Syndrome 1 |
81 |
0.124 |
|
12 |
|
|
ISC004 |
Ischemia |
58 |
0.122 |
|
13 |
|
P
|
HRT032 |
Heart Disease |
75 |
0.119 |
|
14 |
|
P
|
NRB001 |
Neuroblastoma |
72 |
0.118 |
|
15 |
|
P
|
MYP004 |
Myopathy |
70 |
0.117 |
|
16 |
|
|
CNG034 |
Congestive Heart Failure |
69 |
0.116 |
|
17 |
|
P
|
VSC007 |
Vascular Disease |
63 |
0.114 |
|
18 |
|
P
|
FTT008 |
Fatty Liver Disease, Nonalcoholic 1 |
60 |
0.113 |
|
19 |
|
c
|
DBT099 |
Diabetes Mellitus, Type I |
65 |
0.112 |
|
20 |
|
c
|
HYP595 |
Hypertension, Essential |
84 |
0.111 |
|
21 |
|
P
|
ALZ034 |
Alzheimer Disease |
88 |
0.110 |
|
22 |
|
P
|
DBT009 |
Diabetes Mellitus |
64 |
0.109 |
|
23 |
|
P
|
OVR042 |
Ovarian Cancer |
88 |
0.108 |
|
24 |
|
|
HMP009 |
Haemophilus Influenzae |
43 |
0.106 |
|
25 |
|
P
|
DBT026 |
Diabetes Mellitus, Noninsulin-Dependent |
90 |
0.104 |
|
26 |
|
|
WLL004 |
Wallerian Degeneration |
39 |
0.104 |
|
27 |
|
P
|
NRV007 |
Nervous System Disease |
66 |
0.102 |
|
28 |
|
P
|
MTC069 |
Mitochondrial Disorders |
56 |
0.100 |
|
29 |
|
P
|
PRK057 |
Parkinson Disease, Late-Onset |
78 |
0.099 |
|
30 |
|
c
|
ATR087 |
Atrial Standstill 1 |
75 |
0.099 |
|
31 |
|
|
PRP075 |
Peripheral Neuropathy, Myopathy, Hoarseness, and Hearing Loss |
37 |
0.099 |
|
32 |
|
c
|
SVR001 |
Severe Acute Respiratory Syndrome |
62 |
0.097 |
|
33 |
|
|
ALL026 |
Allergic Hypersensitivity Disease |
62 |
0.097 |
|
34 |
|
|
48X005 |
48,xyyy |
39 |
0.095 |
|
35 |
|
|
ART140 |
Arteries, Anomalies of |
52 |
0.094 |
|
36 |
|
P
|
CLR023 |
Colorectal Cancer |
99 |
0.093 |
|
37 |
|
|
ATH013 |
Atherosclerosis Susceptibility |
65 |
0.093 |
|
38 |
|
|
LPD008 |
Lipid Metabolism Disorder |
62 |
0.093 |
|
39 |
|
|
DBT010 |
Diabetic Neuropathy |
54 |
0.091 |
|
40 |
|
|
CYT002 |
Cytokine Deficiency |
42 |
0.091 |
|
41 |
|
P
|
ABD014 |
Abdominal Obesity-Metabolic Syndrome 1 |
64 |
0.090 |
|
42 |
|
P
|
MTC133 |
Mitochondrial Myopathy |
49 |
0.090 |
|
43 |
|
|
LSH001 |
Leishmaniasis |
63 |
0.090 |
|
44 |
|
P
|
KLZ004 |
Kala-Azar 1 |
41 |
0.090 |
|
45 |
|
P
|
HPT023 |
Hepatocellular Carcinoma |
100 |
0.088 |
|
46 |
|
P
|
DMN002 |
Dementia |
66 |
0.088 |
|
47 |
|
|
KHL003 |
Kohlschutter-Tonz Syndrome |
65 |
0.088 |
|
48 |
|
c
|
ACT071 |
Acute Kidney Failure |
60 |
0.086 |
|
49 |
|
|
ERY029 |
Erythermalgia, Primary |
58 |
0.086 |
|
50 |
|
|
SNS003 |
Sensory Peripheral Neuropathy |
54 |
0.086 |
|
51 |
|
|
SKN016 |
Skin Disease |
63 |
0.086 |
|
52 |
|
|
HRW001 |
Hair Whorl |
36 |
0.085 |
|
53 |
|
c
|
DLT002 |
Dilated Cardiomyopathy |
79 |
0.084 |
|
54 |
|
P
|
MYC007 |
Myocardial Infarction |
70 |
0.084 |
|
55 |
|
c
|
NRD033 |
Neurodegeneration with Brain Iron Accumulation 2a |
69 |
0.084 |
|
56 |
|
|
ART016 |
Aortic Aneurysm |
69 |
0.084 |
|
57 |
|
P
|
PSR002 |
Psoriasis |
62 |
0.083 |
|
58 |
|
|
PST011 |
Pustulosis of Palm and Sole |
52 |
0.083 |
|
59 |
|
|
ATX038 |
Ataxia and Polyneuropathy, Adult-Onset |
45 |
0.083 |
|
60 |
|
c
|
LKM061 |
Leukemia, Acute Myeloid |
84 |
0.082 |
|
61 |
|
P
|
ART062 |
Arthrogryposis, Renal Dysfunction, and Cholestasis 1 |
65 |
0.081 |
|
62 |
|
P
|
BRS047 |
Breast Cancer |
97 |
0.081 |
|
63 |
|
P
|
LKM071 |
Leukemia, Chronic Lymphocytic |
79 |
0.081 |
|
64 |
|
|
MTC005 |
Mitochondrial Metabolism Disease |
49 |
0.081 |
|
65 |
|
P
|
LKM062 |
Leukemia, Acute Lymphoblastic |
69 |
0.078 |
|
66 |
|
|
VCC001 |
Vaccinia |
49 |
0.078 |
|
67 |
|
c
|
FNC043 |
Fanconi Anemia, Complementation Group E |
62 |
0.078 |
|
68 |
|
P
|
ENC018 |
Encephalopathy |
61 |
0.078 |
|
69 |
|
|
CRB039 |
Cerebrovascular Disease |
67 |
0.077 |
|
70 |
|
|
NTR005 |
Nutritional Deficiency Disease |
62 |
0.077 |
|
71 |
|
P
|
MYL006 |
Myeloid Leukemia |
60 |
0.077 |
|
72 |
|
|
ANR040 |
Aneurysm |
59 |
0.077 |
|
73 |
|
P
|
EXN002 |
Exanthem |
57 |
0.077 |
|
74 |
|
P
|
HDC001 |
Headache |
57 |
0.077 |
|
75 |
|
|
47X002 |
47,xyy |
49 |
0.077 |
|
76 |
|
|
LSC001 |
Lesch-Nyhan Syndrome |
62 |
0.077 |
|
77 |
|
|
STR067 |
Stroke, Ischemic |
81 |
0.075 |
|
78 |
|
P
|
BDY004 |
Body Mass Index Quantitative Trait Locus 11 |
76 |
0.075 |
|
79 |
|
c
|
HYP836 |
Hypercholesterolemia, Familial, 1 |
73 |
0.075 |
|
80 |
|
P
|
LCT001 |
Lactic Acidosis |
51 |
0.075 |
|
81 |
|
P
|
RSP003 |
Respiratory Failure |
74 |
0.072 |
|
82 |
|
|
PRP027 |
Peripheral Vascular Disease |
71 |
0.072 |
|
83 |
|
|
DWN001 |
Down Syndrome |
70 |
0.072 |
|
84 |
|
|
FLL027 |
Fallopian Tube Carcinoma |
67 |
0.072 |
|
85 |
|
|
MCS002 |
Mucositis |
56 |
0.072 |
|
86 |
|
|
PRP080 |
Peripheral Artery Disease |
53 |
0.072 |
|
87 |
|
|
HYP081 |
Hypolipoproteinemia |
51 |
0.072 |
|
88 |
|
|
SYS003 |
Systolic Heart Failure |
49 |
0.072 |
|
89 |
|
|
PRD004 |
Prediabetes Syndrome |
47 |
0.072 |
|
90 |
|
|
CVD001 |
Covid-19 |
44 |
0.072 |
|
91 |
|
|
TRP009 |
Triple X Syndrome |
42 |
0.072 |
|
92 |
|
|
RST023 |
Resting Heart Rate, Variation in |
41 |
0.072 |
|
93 |
|
c
|
OVR114 |
Ovarian Cancer 1 |
38 |
0.072 |
|
94 |
|
P
|
THR014 |
Thrombocytopenia |
67 |
0.072 |
|
95 |
|
P
|
MYC008 |
Myocarditis |
59 |
0.072 |
|
96 |
|
c
|
AMY091 |
Amyotrophic Lateral Sclerosis 1 |
89 |
0.068 |
|
97 |
|
P
|
PNC035 |
Pancreatic Cancer |
84 |
0.068 |
|
98 |
|
P
|
HYP724 |
Hyperlipoproteinemia, Type Iii |
73 |
0.068 |
|
99 |
|
|
LPP008 |
Lipoprotein Quantitative Trait Locus |
62 |
0.068 |
|
100 |
|
|
MTC114 |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes |
61 |
0.068 |
|
101 |
|
P
|
BCL017 |
B-Cell Lymphoma |
58 |
0.068 |
|
102 |
|
P
|
INF037 |
Inflammatory Bowel Disease |
54 |
0.068 |
|
103 |
|
c
|
PSR017 |
Psoriasis 2 |
53 |
0.068 |
|
104 |
|
c
|
BDY021 |
Body Mass Index Quantitative Trait Locus 20 |
52 |
0.068 |
|
105 |
|
c
|
PSR023 |
Psoriasis 1 |
52 |
0.068 |
|
106 |
|
c
|
BDY020 |
Body Mass Index Quantitative Trait Locus 19 |
52 |
0.068 |
|
107 |
|
c
|
BDY005 |
Body Mass Index Quantitative Trait Locus 9 |
48 |
0.068 |
|
108 |
|
c
|
PSR032 |
Psoriasis 11 |
47 |
0.068 |
|
109 |
|
c
|
BDY019 |
Body Mass Index Quantitative Trait Locus 18 |
47 |
0.068 |
|
110 |
|
c
|
BDY010 |
Body Mass Index Quantitative Trait Locus 4 |
46 |
0.068 |
|
111 |
|
c
|
BDY015 |
Body Mass Index Quantitative Trait Locus 12 |
46 |
0.068 |
|
112 |
|
c
|
BDY017 |
Body Mass Index Quantitative Trait Locus 14 |
45 |
0.068 |
|
113 |
|
c
|
BDY011 |
Body Mass Index Quantitative Trait Locus 10 |
45 |
0.068 |
|
114 |
|
c
|
BDY006 |
Body Mass Index Quantitative Trait Locus 8 |
44 |
0.068 |
|
115 |
|
c
|
BDY012 |
Body Mass Index Quantitative Trait Locus 7 |
44 |
0.068 |
|
116 |
|
c
|
PSR028 |
Psoriasis 7 |
42 |
0.068 |
|
117 |
|
c
|
PSR018 |
Psoriasis 13 |
41 |
0.068 |
|
118 |
|
|
MTC023 |
Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes |
34 |
0.068 |
|
119 |
|
|
CHG001 |
Chagas Disease |
66 |
0.067 |
|
120 |
|
|
ATX031 |
Ataxia, Combined Cerebellar and Peripheral, with Hearing Loss and Diabetes Mellitus |
58 |
0.067 |
|
121 |
|
|
HRN029 |
Hearing Loss, Noise-Induced |
37 |
0.067 |
|
122 |
|
|
ACR006 |
Aceruloplasminemia |
65 |
0.064 |
|
|
124 |
|
|
PSD063 |
Pseudohyperkalemia, Familial, 2, Due to Red Cell Leak |
56 |
0.064 |
|
125 |
|
|
HLX001 |
Helix Syndrome |
47 |
0.064 |
|
126 |
|
P
|
ATX024 |
Ataxia-Oculomotor Apraxia 3 |
44 |
0.064 |
|
127 |
|
|
DBT002 |
Diabetic Autonomic Neuropathy |
41 |
0.064 |
|
128 |
|
P
|
TRN020 |
Turner Syndrome |
67 |
0.060 |
|
129 |
|
|
OST159 |
Osteogenic Sarcoma |
66 |
0.060 |
|
130 |
|
|
SRC014 |
Sarcoma |
65 |
0.060 |
|
131 |
|
|
KRN002 |
Kearns-Sayre Syndrome |
63 |
0.060 |
|
132 |
|
P
|
PLY019 |
Polyneuropathy |
56 |
0.060 |
|
133 |
|
P
|
LTR001 |
Lateral Sclerosis |
54 |
0.060 |
|
134 |
|
|
PLY118 |
Polyglucosan Body Myopathy 1 with or Without Immunodeficiency |
53 |
0.060 |
|
135 |
|
P
|
OVR082 |
Overgrowth Syndrome |
50 |
0.060 |
|
136 |
|
c
|
CHR095 |
Chronic Progressive External Ophthalmoplegia |
46 |
0.060 |
|
137 |
|
P
|
MTC004 |
Mitochondrial Encephalomyopathy |
44 |
0.060 |
|
138 |
|
c
|
HYP272 |
Hypercholesterolemia, Familial, 3 |
44 |
0.060 |
|
139 |
|
c
|
BDY007 |
Body Mass Index Quantitative Trait Locus 1 |
42 |
0.060 |
|
140 |
|
|
TRD008 |
Triiodothyronine Receptor Auxiliary Protein |
34 |
0.060 |
|
141 |
|
|
MYL069 |
Myeloma, Multiple |
85 |
0.054 |
|
142 |
|
P
|
ATX030 |
Ataxia-Telangiectasia |
82 |
0.054 |
|
143 |
|
P
|
LFR001 |
Li-Fraumeni Syndrome |
72 |
0.054 |
|
144 |
|
P
|
ATS364 |
Autism |
70 |
0.054 |
|
145 |
|
P
|
LKM002 |
Leukemia |
68 |
0.054 |
|
146 |
|
c
|
ATS007 |
Autism Spectrum Disorder |
67 |
0.054 |
|
147 |
|
c
|
MCR129 |
Microvascular Complications of Diabetes 1 |
66 |
0.054 |
|
148 |
|
P
|
GLM045 |
Glioma |
63 |
0.054 |
|
149 |
|
P
|
CRN300 |
Coronary Heart Disease 1 |
63 |
0.054 |
|
150 |
|
P
|
SLP005 |
Sleep Disorder |
59 |
0.054 |
|
151 |
|
c
|
FML035 |
Familial Hyperlipidemia |
55 |
0.054 |
|
152 |
|
|
HYP005 |
Hypokalemia |
55 |
0.054 |
|
153 |
|
|
TLN003 |
Telangiectasis |
52 |
0.054 |
|
154 |
|
|
DBT004 |
Diabetic Polyneuropathy |
49 |
0.054 |
|
155 |
|
c
|
LFR007 |
Li-Fraumeni Syndrome 2 |
45 |
0.054 |
|
156 |
|
|
CND006 |
Candida Glabrata |
32 |
0.054 |
|
157 |
|
|
MTC015 |
Mitochondrial Dna-Associated Leigh Syndrome and Narp |
24 |
0.054 |
|
158 |
|
P
|
PHC003 |
Pheochromocytoma |
71 |
0.047 |
|
159 |
|
P
|
MSC005 |
Muscular Dystrophy |
66 |
0.047 |
|
160 |
|
P
|
HML002 |
Hemolytic Anemia |
63 |
0.047 |
|
161 |
|
|
SFT003 |
Soft Tissue Sarcoma |
56 |
0.047 |
|
162 |
|
|
PST021 |
Postpartum Depression |
50 |
0.047 |
|
163 |
|
|
TRY001 |
Trypanosomiasis |
50 |
0.047 |
|